Stock Scorer

Guardant Health, Inc. (GH)

Guardant Health, Inc. reported revenue of 335M USD for the quarter ending 30 June 2026, up 44.3% from 232.1M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 335M +44.3%
Gross Profit Q2 '26 · ending 30 June 2026 219M +45.2%
Operating Income Q2 '26 · ending 30 June 2026 -129.1M —
Net Income Q2 '26 · ending 30 June 2026 -120.1M —
Cost of Revenue Q2 '26 · ending 30 June 2026 115.9M +42.8%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -57.8M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -69.5M —
Shares Outstanding Q2 '26 · ending 30 June 2026 132.9M +7.3%
EPS Q2 '26 · ending 30 June 2026 -3.49 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 982M-437.2M-416.3M-233.1M
20242024-12-31 739M-443.6M-436.4M-274.9M
20232023-12-31 563.9M-564.7M-479.4M-345.5M
20222022-12-31 449.5M-544.4M-654.6M-386.9M
20212021-12-31 373.7M-411M-384.8M-284.1M
20202020-12-31 286.7M-254.9M-246.3M-140.1M
20192019-12-31 214.4M-82.4M-75.7M-65.9M
20182018-12-31 90.6M-92.9M-85.1M-92.4M
20172017-12-31 49.8M-76.6M-83.2M-78.9M
20162016-12-31 25.2M-43.8M-46.1M-38.5M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30335M
Q1 '262026-03-31301.7M
Q4 '252025-12-31281.3M
Q3 '252025-09-30265.2M
Q2 '252025-06-30232.1M
Q1 '252025-03-31203.5M
Q4 '242024-12-31201.8M
Q3 '242024-09-30191.5M
Q2 '242024-06-30177.2M
Q1 '242024-03-31168.5M
Q4 '232023-12-31155.1M
Q3 '232023-09-30143M
Q2 '232023-06-30137.2M
Q1 '232023-03-31128.7M
Q4 '222022-12-31126.9M
Q3 '222022-09-30117.4M
Q2 '222022-06-30109.1M
Q1 '222022-03-3196.1M
Q4 '212021-12-31108.1M
Q3 '212021-09-3094.8M

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q2 '262026-06-30219M
Q1 '262026-03-31196.7M
Q4 '252025-12-31181.8M
Q3 '252025-09-30171.6M
Q2 '252025-06-30150.9M
Q1 '252025-03-31128.7M
Q4 '242024-12-31124.2M
Q3 '242024-09-30117M
Q2 '242024-06-30104.8M
Q1 '242024-03-31103.2M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-129.1M
Q1 '262026-03-31-121.3M
Q4 '252025-12-31-120.8M
Q3 '252025-09-30-99M
Q2 '252025-06-30-106.4M
Q1 '252025-03-31-111M
Q4 '242024-12-31-126M
Q3 '242024-09-30-117.3M
Q2 '242024-06-30-100.6M
Q1 '242024-03-31-99.7M
Q4 '232023-12-31-197.5M
Q3 '232023-09-30-113.5M
Q2 '232023-06-30-119.6M
Q1 '232023-03-31-134.1M
Q4 '222022-12-31-146.1M
Q3 '222022-09-30-144.6M
Q2 '222022-06-30-130.3M
Q1 '222022-03-31-123.3M
Q4 '212021-12-31-98.2M
Q3 '212021-09-30-107.3M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-120.1M
Q1 '262026-03-31-112.1M
Q4 '252025-12-31-128.5M
Q3 '252025-09-30-92.7M
Q2 '252025-06-30-99.9M
Q1 '252025-03-31-95.2M
Q4 '242024-12-31-111M
Q3 '242024-09-30-107.8M
Q2 '242024-06-30-102.6M
Q1 '242024-03-31-115M
Q4 '232023-12-31-187M
Q3 '232023-09-30-86.1M
Q2 '232023-06-30-72.8M
Q1 '232023-03-31-133.5M
Q4 '222022-12-31-139.9M
Q3 '222022-09-30-162M
Q2 '222022-06-30-229.4M
Q1 '222022-03-31-123.2M
Q4 '212021-12-31-72.3M
Q3 '212021-09-30-107.5M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30115.9M
Q1 '262026-03-31104.9M
Q4 '252025-12-3199.5M
Q3 '252025-09-3093.6M
Q2 '252025-06-3081.2M
Q1 '252025-03-3174.7M
Q4 '242024-12-3177.6M
Q3 '242024-09-3074.5M
Q2 '242024-06-3072.4M
Q1 '242024-03-3165.3M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-57.8M
Q1 '262026-03-31-65.6M
Q4 '252025-12-31-26.4M
Q3 '252025-09-30-35.4M
Q2 '252025-06-30-60.3M
Q1 '252025-03-31-62.7M
Q4 '242024-12-31-64.5M
Q3 '242024-09-30-51.1M
Q2 '242024-06-30-94M
Q1 '242024-03-31-30.3M
Q4 '232023-12-31-78.7M
Q3 '232023-09-30-77.8M
Q2 '232023-06-30-94M
Q1 '232023-03-31-74.4M
Q4 '222022-12-31-90.7M
Q3 '222022-09-30-78.2M
Q2 '222022-06-30-111.9M
Q1 '222022-03-31-28.6M
Q4 '212021-12-31-77M
Q3 '212021-09-30-53.1M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-69.5M
Q1 '262026-03-31-71.2M
Q4 '252025-12-31-54.2M
Q3 '252025-09-30-45.8M
Q2 '252025-06-30-65.9M
Q1 '252025-03-31-67.1M
Q4 '242024-12-31-83.4M
Q3 '242024-09-30-55.3M
Q2 '242024-06-30-99.1M
Q1 '242024-03-31-37.2M
Q4 '232023-12-31-82.8M
Q3 '232023-09-30-80.2M
Q2 '232023-06-30-100.5M
Q1 '232023-03-31-82M
Q4 '222022-12-31-100.8M
Q3 '222022-09-30-99.9M
Q2 '222022-06-30-135M
Q1 '222022-03-31-51.3M
Q4 '212021-12-31-101.6M
Q3 '212021-09-30-75.3M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30132.9M
Q1 '262026-03-31131.3M
Q3 '252025-09-30124.8M
Q2 '252025-06-30124.1M
Q1 '252025-03-31123.9M
Q3 '242024-09-30123.1M
Q2 '242024-06-30122.4M
Q1 '242024-03-31121.7M
Q3 '232023-09-30117.7M
Q2 '232023-06-30108.8M
Q1 '232023-03-31102.7M
Q3 '222022-09-30102.3M
Q2 '222022-06-30102M
Q1 '222022-03-31101.9M
Q3 '212021-09-30101.4M
Q2 '212021-06-30101.2M
Q1 '212021-03-31101M
Q3 '202020-09-3099.6M
Q2 '202020-06-3096M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-3.49
Q1 '262026-03-31-3.39
Q4 '252025-12-31-3.31
Q3 '252025-09-30-3.21
Q2 '252025-06-30-3.35
Q1 '252025-03-31-3.39
Q4 '242024-12-31-3.56
Q3 '242024-09-30-4.28
Q2 '242024-06-30-4.13
Q1 '242024-03-31-3.96
Q4 '232023-12-31-4.32
Q3 '232023-09-30-4.07
Q2 '232023-06-30-4.92
Q1 '232023-03-31-6.50
Q4 '222022-12-31-6.41
Q3 '222022-09-30-5.93
Q2 '222022-06-30-5.41
Q1 '222022-03-31-4.12
Q4 '212021-12-31-4.00
Q3 '212021-09-30-4.05